Didanosine
- TRADE NAME: Videx (Bristol-Myers Squibb)
- INDICATIONS: Advanced HIV infection
- CLASS: Antiretroviral, Nucleoside analog reverse transcriptase inhibitor
- HALF-LIFE: 1.5 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Acetaminophen, Amprenavir, Ciprofloxacin, Corticosteroids, Dapsone, Darunavir, Febuxostat, Gemifloxacin, Indinavir, Itraconazole, Ketoconazole, Levofloxacin, Lomefloxacin, Lopinavir, Moxifloxacin, Norfloxacin, Ofloxacin, Ribavirin, Ribavirin, Sulfones, Tenofovir Disoproxil, Tetracycline, Tipranavir, Voriconazole
PREGNANCY CATEGORY: B
PANCREATITIS, LACTIC ACIDOSIS and HEPATOMEGALY with STEATOSIS
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
